Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million

HONG KONG, June 16, 2023 /PRNewswire/ — On June 11, 2023, Viva Biotech Holdings Group (1873.HK) announced that Viva Shanghai, the primary entity for Viva Biotech’s CRO business, successfully raised nearly US$ 150 million through the transfer of approximately 24% of its equity interest to Temasek, HLC, and True Light. Furthermore, the listed entity of … Read more

Latest Updates of 9 Viva’s Portfolio Companies

HONG KONG, June 2, 2023 /PRNewswire/ — Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, 9 of Viva’s portfolio companies have achieved significant results and … Read more